Merrill J. Egorin
Molecular Therapeutics/Drug Discovery Program
University of Pittsburgh Cancer Institute
PA 15213
USA
Name/email consistency: high
- Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Egorin, M.J., Lagattuta, T.F., Hamburger, D.R., Covey, J.M., White, K.D., Musser, S.M., Eiseman, J.L. Cancer Chemother. Pharmacol. (2002)
- Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Egorin, M.J., Zuhowski, E.G., McCully, C.M., Blaney, S.M., Kerr, J.Z., Berg, S.L., Balis, F.M. Clin. Cancer Res. (2002)
- Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Egorin, M.J., Yuan, Z.M., Sentz, D.L., Plaisance, K., Eiseman, J.L. Cancer Chemother. Pharmacol. (1999)
- Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Egorin, M.J., Zuhowski, E.G., Sentz, D.L., Dobson, J.M., Callery, P.S., Eiseman, J.L. Cancer Chemother. Pharmacol. (1999)